This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (627) Chemotherapy and Side Effects Management (87) Health Services Research (522) Longitudinal and Cohort Studies in Public Health (357) Lung Cancer (49) Precision Medicine and Genetics (68) Respiratory Medicine (125)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/51381, first published .
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation–Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy

Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation–Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy

Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation–Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy

Authors of this article:

Phyu Sin Aye1 Author Orcid Image ;   Joanne Barnes2 Author Orcid Image ;   George Laking3 Author Orcid Image ;   Laird Cameron4 Author Orcid Image ;   Malcolm Anderson5 Author Orcid Image ;   Brendan Luey6 Author Orcid Image ;   Stephen Delany7 Author Orcid Image ;   Dean Harris8 Author Orcid Image ;   Blair McLaren9 Author Orcid Image ;   Elliott Brenman10 Author Orcid Image ;   Jayden Wong11 Author Orcid Image ;   Ross Lawrenson12 Author Orcid Image ;   Michael Arendse13 Author Orcid Image ;   Sandar Tin Tin14 Author Orcid Image ;   Mark Elwood14 Author Orcid Image ;   Philip Hope15 Author Orcid Image ;   Mark James McKeage1, 4, 16 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Aye P, Barnes J, Laking G, Cameron L, Anderson M, Luey B, Delany S, Harris D, McLaren B, Brenman E, Wong J, Lawrenson R, Arendse M, Tin Tin S, Elwood M, Hope P, McKeage M. Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor–Mutated Nonsquamous Non–Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study. JMIR Cancer 2025;11:e65118 View